×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
0
Days
0
Hours
0
Minutes
0
Seconds


Monday, September 15th 2025
01pm to 01:45pm (GMT+2)

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
Add to calendar Notify me
 Browser notifications are enabled

Contexte :

 

Autour de deux cas cliniques, discussion du rôle de l’immunothérapie, chimiothérapie néoadjuvante et de la radio chimiothérapie et curiethérapie dans le cancer du col avancé avec les recommandations de Saint Paul Vence 2025.

 

Intervenants :

 

Dr Sarah Betrian Lagarde

Dr Abel Cordoba Largo

 

Programme :

 

Retour d’expérience de l’utilisation du pembrolizumab pour les cancers du col localement avancés dans la pratique quotidienneDr Sarah Betrian Lagarde & Dr Abel Cordoba Largo

 

Shooting date : 2025-09-15
Last update : 2025-06-19
Dr Sarah Betrian Lagarde
Toulouse , France
Oncology
Dr Abel Cordoba Largo
Lille, France
Radiotherapy

Suggestions

Wednesday, March 26th 2025 from 01pm to 01:45pm (GMT+1)
Honolulu : Wednesday, March 26th 2025 from 01am to 01:45am (GMT+1)
San Francisco : Wednesday, March 26th 2025 from 03am to 03:45am (GMT+1)
New York : Wednesday, March 26th 2025 from 06am to 06:45am (GMT+1)
Buenos Aires : Wednesday, March 26th 2025 from 08am to 08:45am (GMT+1)
London / Dublin : Wednesday, March 26th 2025 from 11am to 11:45am (GMT+1)
Paris / Berlin : Wednesday, March 26th 2025 from 12pm to 12:45pm (GMT+1)
Istanbul : Wednesday, March 26th 2025 from 01pm to 01:45pm (GMT+1)
Moscou / Dubaï : Wednesday, March 26th 2025 from 03pm to 03:45pm (GMT+1)
Bangkok : Wednesday, March 26th 2025 from 06pm to 06:45pm (GMT+1)
Shanghai : Wednesday, March 26th 2025 from 07pm to 07:45pm (GMT+1)
Tokyo : Wednesday, March 26th 2025 from 08pm to 08:45pm (GMT+1)
Sydney : Wednesday, March 26th 2025 from 09pm to 09:45pm (GMT+1)
Wellington : Wednesday, March 26th 2025 from 11pm to 11:45pm (GMT+1)

Comment prendre en charge un cancer de l'endomètre avancé ?

Cancer de l’endomètre avancé en rechute précoce : que proposer en 2025 ? (épisode 2)

Share
Saturday, March 22nd 2025 from 09:30am to 12:30pm (GMT+1)
Honolulu : Friday, March 21st 2025 from 09:30pm to 12:30am (GMT+1)
San Francisco : Friday, March 21st 2025 from 11:30pm to 02:30am (GMT+1)
New York : Saturday, March 22nd 2025 from 02:30am to 05:30am (GMT+1)
Buenos Aires : Saturday, March 22nd 2025 from 04:30am to 07:30am (GMT+1)
London / Dublin : Saturday, March 22nd 2025 from 07:30am to 10:30am (GMT+1)
Paris / Berlin : Saturday, March 22nd 2025 from 08:30am to 11:30am (GMT+1)
Istanbul : Saturday, March 22nd 2025 from 09:30am to 12:30pm (GMT+1)
Moscou / Dubaï : Saturday, March 22nd 2025 from 11:30am to 02:30pm (GMT+1)
Bangkok : Saturday, March 22nd 2025 from 02:30pm to 05:30pm (GMT+1)
Shanghai : Saturday, March 22nd 2025 from 03:30pm to 06:30pm (GMT+1)
Tokyo : Saturday, March 22nd 2025 from 04:30pm to 07:30pm (GMT+1)
Sydney : Saturday, March 22nd 2025 from 05:30pm to 08:30pm (GMT+1)
Wellington : Saturday, March 22nd 2025 from 07:30pm to 10:30pm (GMT+1)

Transpyrenean Oncogynae Symposium

Ovarian cancer: from molecular insights to multidisciplinary strategies

Share
Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 19th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, September 19th 2023 from 09am to 10:30am (GMT+2)
New York : Tuesday, September 19th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, September 19th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, September 19th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, September 20th 2023 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, September 20th 2023 from 05am to 06:30am (GMT+2)

Prise en charge des carcinomes séreux de bas grade en 2023

Share
Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
Honolulu : Wednesday, March 20th 2024 from 07am to 08am (GMT+1)
San Francisco : Wednesday, March 20th 2024 from 09am to 10am (GMT+1)
New York : Wednesday, March 20th 2024 from 12pm to 01pm (GMT+1)
Buenos Aires : Wednesday, March 20th 2024 from 02pm to 03pm (GMT+1)
London / Dublin : Wednesday, March 20th 2024 from 05pm to 06pm (GMT+1)
Paris / Berlin : Wednesday, March 20th 2024 from 06pm to 07pm (GMT+1)
Istanbul : Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
Moscou / Dubaï : Wednesday, March 20th 2024 from 09pm to 10pm (GMT+1)
Bangkok : Thursday, March 21st 2024 from 12am to 01am (GMT+1)
Shanghai : Thursday, March 21st 2024 from 01am to 02am (GMT+1)
Tokyo : Thursday, March 21st 2024 from 02am to 03am (GMT+1)
Sydney : Thursday, March 21st 2024 from 03am to 04am (GMT+1)
Wellington : Thursday, March 21st 2024 from 05am to 06am (GMT+1)

Immunothérapies et inhibiteurs de PARP dans la prise en charge du cancer de l’endomètre avancé ...

éclairages du congrès de la SGO

Share
Scroll Up